Viewing StudyNCT00049179



Ignite Creation Date: 2024-05-05 @ 11:27 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00049179
Status: COMPLETED
Last Update Posted: 2015-03-06
First Post: 2002-11-12

Brief Title: S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Sponsor: SWOG Cancer Research Network
Organization: SWOG Cancer Research Network

Organization Data

Organization: SWOG Cancer Research Network
Class: NETWORK
Study ID: S0117
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: SWOG Cancer Research Network
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH